THE HAGUE, 03 December 2022, (TON): European Union’s drug regulator said “cough medicines containing the chemical pholcodine should be banned due to the risk of potentially deadly allergic reactions in people under general anaesthetic.”
The European Medicines Agency recommended that treatments containing pholcodine, which is used in adults and children to treat dry coughs, should be withdrawn from sale.
To muscle relaxants in the anaesthetic, the Amsterdam-based watchdog said “use of pholcodine in the 12 months before general anaesthesia is a risk factor for developing an anaphylactic reaction.”
Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.